Infliximab for Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Retrospective Study-Reference-Cited by-同舟云学术

Infliximab for Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Retrospective Study

Published:2011-04 Issue:4 Volume:158 Page:644-649.e1
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Son Mary Beth,Gauvreau Kimberlee,Burns Jane C.,Corinaldesi Elena,Tremoulet Adriana H.,Watson Virginia E.,Baker Annette,Fulton David R.,Sundel Robert P.,Newburger Jane W.

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology, and Child Health

Reference32 articles.

1. The treatment of Kawasaki syndrome with intravenous gamma globulin;Newburger;N Engl J Med,1986

2. Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease;Han;Arch Pediatr Adolesc Med,2000

3. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan;Uehara;Pediatr Infect Dis J,2008

4. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group;Burns;Pediatr Infect Dis J,1998

5. Resistance to intravenous immunoglobulin in children with Kawasaki disease;Tremoulet;J Pediatr,2008

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research perspective in the clinical management of Kawasaki disease;Frontiers in Pediatrics;2024-07-09

2. Knowledge framework of intravenous immunoglobulin resistance in the field of Kawasaki disease: A bibliometric analysis (1997−2023);Immunity, Inflammation and Disease;2024-05

3. Efficacy and safety of infliximab in the treatment of Kawasaki disease: A systematic review and meta-analysis;European Journal of Pediatrics;2024-01-19

4. Reshaping the Therapeutic Landscape: Drug Repurposing for Emerging Infectious Diseases and Rare Diseases;Drug Repurposing;2024

5. Current knowledge of TNF-α monoclonal antibody infliximab in treating Kawasaki disease: a comprehensive review;Frontiers in Immunology;2023-10-23